AMWL Stock Analysis: Buy, Sell, or Hold?
AMWL - American Well Corporation
$5.44
0.15 (2.84%)
β²
5d:
-1.27%
30d:
-0.37%
90d:
+10.79%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 07, 2026
Get Alerted When AMWL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
β BUY SIGNAL: AMWL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
β BUY SIGNAL: AMWL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: AMWL is currently trading at $5.44, which is considered fair relative to its 30-day fair value range of $5.33 to $5.69.
Technical Outlook: Technically, AMWL is in a strong uptrend. Immediate support is located at $5.10, while resistance sits at $5.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.25 (+18.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AMWL is in a strong uptrend. Immediate support is located at $5.10, while resistance sits at $5.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.25 (+18.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$5.33 -
$5.69
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.9%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($6.25)
Fair Price Analysis
30-Day Fair Range
$5.33 -
$5.69
Current vs Fair Value
FAIR
Expected Move (7 Days)
Β±$0.66
(12.1%)
Support & Resistance Levels
Support Level
$5.10
Resistance Level
$5.90
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.67
Wall Street Target
$6.25
(+18.1%)
Revenue Growth (YoY)
-22.1%
Profit Margin
-38.4%
Share & Embed Analysis
Last updated: April 02, 2026 3:25 PM ET
Data refreshes hourly during market hours. Next update: 4:25 PM
Data refreshes hourly during market hours. Next update: 4:25 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMWL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Paul Francis Mcneice
SELL
384 shares
2026-01-02
Phyllis Gotlib
SELL
3707 shares
2026-01-02
Dmitry Zamansky
SELL
6243 shares
2026-01-02
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 60 BUY |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$90 | 62 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 67 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 52 HOLD |